Drug · DIN 02303353
RANITIDINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 20, 2014; first marketed June 22, 2009.
- Drug Identification Number (DIN)
- 02303353
- Company (DIN owner)
- Sorres Pharma IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ranitidine A02BA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANITIDINE (RANITIDINE HYDROCHLORIDE) | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 8, 2010: NOC 11228Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- December 20, 2007: NOC 9258Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named RANITIDINE
- DIN 00740748 · Cancelled Post Market
- DIN 00740756 · Cancelled Post Market
- DIN 02245615 · Cancelled Pre Market
- DIN 02286106 · Cancelled Post Market
- DIN 02286114 · Cancelled Post Market
- DIN 02303388 · Cancelled Post Market
- DIN 02343436 · Cancelled Pre Market
- DIN 02343444 · Cancelled Pre Market
- DIN 02353016 · Dormant
- DIN 02353024 · Dormant
- DIN 02385953 · Cancelled Post Market
- DIN 02385961 · Cancelled Post Market